Boston Scientific Corporation vs Enbridge Inc — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Enbridge Inc trades at $51.74 (market cap $112.62B). The key difference: Enbridge Inc is the larger of the two by market cap, and Enbridge Inc pays a 5.34% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | ENB | |
|---|---|---|
Market Cap | $74.19B | $112.62B |
Sector | Health | Energy |
52-Week High | $108.14 | $58.04 |
52-Week Low | $42.63 | $45.23 |
Enterprise Value | $86.27B | $196.53B |
Dividend Yield | — | 5.34% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →